Paclitaxel and Mortality Following Peripheral Angioplasty: An Adjusted and Case Matched Multicentre Analysis
- 1 August 2020
- journal article
- research article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 60 (2) , 220-229
Abstract
No abstract availableKeywords
Funding Information
- NIHR
- Amgen Inc.
- Regeneron
- Abbott
- University of Leicester
This publication has 33 references indexed in Scilit:
- Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national populationJournal of Vascular Surgery, 2014
- Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and StentingCardioVascular and Interventional Radiology, 2014
- Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal arteryJournal of Vascular Surgery, 2014
- Validation of the Charlson Comorbidity Index in Acutely Hospitalized Elderly Adults: A Prospective Cohort StudyJournal of the American Geriatrics Society, 2014
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Adaptation and validation of the Charlson Index for Read/OXMIS coded databasesBMC Family Practice, 2010
- New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortalityJournal of Clinical Epidemiology, 2004
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987